Although significant research has been done to find effective drugs against coronavirus
disease 2019 (COVID‐19) caused by severe acute respiratory syndrome coronavirus 2 …

Abstract Coronavirus disease 2019 (COVID-19) is an ongoing global pandemic caused by
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Type I and III interferon …

Type 1 interferons have a broad antiviral activity in vitro and are currently evaluated in a
clinical trial to treat MERS-CoV. In this review, we discuss preliminary data concerning the …

The recently public health crises in the world is emerged by spreading the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) also named COVID-19. The virus is …

Recent studies have identified an association between perturbed type I interferon (IFN)
responses and the severity of coronavirus disease 2019 (COVID-19). IFNα intervention may …

Abstract Coronavirus disease 2019 (COVID‐19) is globally rampant, and to curb the growing
burden of this disease, in‐depth knowledge about its pathophysiology is needed. This was …

There is an urgent need to identify antivirals to curtail the COVID-19 pandemic. Herein, we
report the sensitivity of SARS-CoV-2 to recombinant human interferons α and β (IFNα/β) …

Coronavirus disease 2019 (COVID-19) is an infectious disease caused by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2). The ability of our cells to secrete type I …

Background Recently, a new coronavirus spreads rapidly throughout the countries and
resulted in a worldwide epidemic. Interferons have direct antiviral and immunomodulatory …

Numerous immunomodulating agents are currently being studied in clinical trials for the
treatment of COVID-19, including interferon therapies. Interferons are naturally occurring …